India is a major exporter of medicines to LMIC (Low and Middle-Income Countries) which require WHO GMP certification. There are around 2,000 units in the MSME category in the country having WHO GMP certification.
Despite moderation in margin pressure, a rise in input costs for some medications can derail pharma sector's recovery, say analysts
"We value LPC (Lupin) at 22x 12M forward earnings to arrive at a price target of Rs 610," Motilal Oswal said. The pharma major's shares closed at Rs 737 apiece at the end of the last trading session.
Many Indian digital healthcare startups are focussed on accessibility and affordability, said David Shulkin, former US secretary of veterans affairs, who currently advises Indegene on using digital tools to help life sciences companies.
If doctors are concerned about the quality of generic drugs and hesitate to prescribe them, how do they decide which medicines patients should take?
The Medical Council of India's (now Medical Commission of India's) rules for doctors and the Uniform Code of Pharmaceutical Marketing Practices have elaborate guidelines to curb such practices, but with no real statutory backing they remain on paper even as the patients suffer.
Moneycontrol takes you into India’s poppy fields to explain what opium derivatives are used for and gives you a whiff of this narcotic’s potent economic potential.
Drug suppliers rethink their investment strategy as continuous price erosion hurts profitability and returns from the US market
Despite a code by the Medical Council of India that prohibits gifts from pharma companies to doctors that came into effect over a decade back, the practice has continued as there is no law barring the firms from offering the largesse to doctors
Health officials believe that many medicines, being sold under the same name in India, put patients' safety at risk
Manisha Girotra, who previously headed the Indian unit of Swiss bank UBS and is well known in the industry, said she expects deals in sectors such as financials, telecoms and pharmaceuticals to continue driving M&A activity in the South Asian nation.
US president-elect claimed pharmaceutical companies were “getting away with murder†with respect to drug pricing; outsourcing of jobs by US firms will soon be a thing of the past.
Domestic pharmaceutical companies are likely to report subdued sales, EBITDA and PAT figures in the second quarter of this fiscal, even as the formulations business may see a strong recovery, Reliance Securities said in its report.
"As on date, 660 pharmaceutical companies have registered in the Integrated Pharmaceutical Database Management System (IPDMS) and 58,027 product details have been entered," Minister of State for Chemicals and Fertilisers Mansukh Lal Mandaviya said in a written reply to the Rajya Sabha.
The High Court has said that these companies are unlikely to take any further price cuts over the WPI which would be under the revision of the national list of essential medicines, reports Ekta Batra of CNBC-TV18.
The government on June 20 allowed up to 74 percent foreign direct investment in the existing pharmaceutical companies through automatic route, with an aim to promote the sector
Various issues pertaining to waste management and problems faced by the units were discussed at length and the units have agreed to comply with the new Rules, official sources said today.
According to a proposal of the Finance Ministry, FDI up to 49 percent should be allowed through the automatic route and anything beyond through approval of the Foreign Investment Promotion Board (FIPB), sources said.
The five drugs are for treatment of cancer or other major diseases, and are very expensive as they are patented or imported, Li Bin head of National Health and Family Planning Commission said today.
"Greater scrutiny by USFDA is emerging as a key challenge for the (Indian) pharmaceutical sector. New product approvals and margins of pharma companies are at risk but credit profiles are unlikely to be impacted," said the report by rating agency Icra.
At the Healthcare Excellence Summit 2015, organized by Worldwide Achievers, Dr. Rinky Kapoor, cosmetic dermatologist and laser skin ...
Adding a new feather in his cap, renowned plastic surgeon, Dr. Debraj Shome of the Esthetic Clinics, Mumbai was named the “Best Plastic Surgeon ...
In the last nine months, the government has taken many right steps to improve the economy, says Shiv Puri, founder and MD of TVF Capital Advisors. It now needs to focus especially on the infrastructure sector in the Budget, he adds.
"The Cabinet will review the FDI policy in pharmaceutical sector on Monday," an official said. The Department of Industrial Policy and Promotion (DIPP) has proposed to reduce FDI cap from 100 percent to 49 percent in the "rare or critical pharma verticals."
A parliamentary committee today suggested a 'blanket ban' on FDI in existing pharmaceutical companies saying the policy in the sensitive sector should be dictated by public good.